Opportunities
Innovate UK / Grant

Advancing innovation in accelerated cancer diagnosis

Innovate UK

Source Company profile

Summary

Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.

AI AI analytics AI analytics partner cancer cancer diagnostics clinical validation collaboration compliance gap consortium consortium-only data analytics data engineering DCB0129 DCB0160 diagnostics DSPT DTAC early diagnosis Funding GDPR grant healthcare health data health data governance health economics information governance Innovate UK ISO 13485 ISO 27001 machine learning MHRA NHS no-bid-as-lead no-bid-lead partner-if-strong-lead partner-only regulatory SaMD

No AI analysis yet

Once the assessment worker runs, the scored recommendation will be stored for this company profile.

Original Source

Open source
https://apply-for-innovation-funding.service.gov.uk/competition/2527/overview/d48f61f8-2bd5-4067-9c05-29dd08487623 
Advancing innovation in accelerated cancer diagnosis Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. Eligibility This competition is open to collaborations only. To lead a collaborative project your organisation must be a UK registered business of any size, an academic institution or an NHS organisation. The consortium must contain at least one UK registered micro, small or medium sized enterprise (SME) claiming grant funding on this application. Closing soon Opened: 1 September 2026 Closes: 28 October 2026